This website uses cookies

We use cookies to personalize content and ads, to provide social media features and to analyze our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services. We will only use cookies based on your decision.

Siemens Healthineers

Ultrasound Derived Fat Fraction (UDFF) White Paper

Delivering early liver diagnosis: the difference is in the details

ACUSON Sequoia Reflection

MASLD (Metabolic dysfunction-associated steatotic liver disease) is the most common cause of chronic liver disease globally. 20% to 30% of people with a MASLD diagnosis progress to a MASH diagnosis (Metabolic dysfunction-associated steatohepatitis), which can lead to advanced fibrosis, cirrhosis, or liver failure with an estimated lifetime cost of $222B in inpatient care.  

Qualitative assessment of hepatic steatosis can be subjective. Conventional methods of ultrasound-based liver fat quantification can be difficult to understand. Ultrasound Derived Fat Fraction (UDFF) on the ACUSON Sequoia is fast, simple and intuitive. UDFF, with a total exam time of less than 1 minute, can classify hepatic steatosis as an index value greater than 5%*, delivering a similar clinical utility as MRI-PDFF1,2

Download the UDFF white paper to learn how to manage hepatic steatosis through liver fat quantification, to aid in successful clinical assessment.

Complete the form below to access the UDFF liver ultrasound whitepaper and sign up for our email list around related topics.

To receive the document for free, please fill out the form below. In return, we will provide you the document and further marketing communication. The information you provide below will be processed as described further in the Privacy Notice.

*Required

*
1
2
Subscription Button Icon
Be the first to know about our events, training, and news